Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Staying motivated to save money can be challenging. Explore effective strategies to keep your savings goals in sight and stay committed.
18,632 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
New buyers grapple with hidden costs beyond the mortgage. This analysis identifies eight charges often overlooked and...
Two popular ETFs divide energy exposure: XOP tracks producers, while OIH tracks oil services. This piece breaks down ...
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
BlackRock indicates bitcoin’s portfolio role is evolving toward a small, strategic allocation as more institutions se...
As rate dynamics shift in 2026, investors weigh a dividend portfolio that starts with a strong yield but relies on gr...
Nokia’s latest move isn't about handsets—it's about AI-friendly data-center networks. The Nokia acquired Infinera qui...
Micron Technology sparked a broad tech rally after investors moved past AI-bearish sentiment, lifting major indices a...
General Motors stock surged 65% in the last year, leaving investors wondering if the rally has legs. This article cut...
A viral duck became the centerpiece of a commercial shoot outside Azteca Stadium, but FIFA rules prevented him from s...
Micron, SanDisk, and Western Digital led a roughly 7% slide in memory names Friday as investors lock in gains after a...
FuelCell Energy surges on a major data-center deal, while Bloom Energy retreats, underscoring a rare divergence in th...